|
|
Article: Inspire Pharmaceuticals Announces Collaboration With Cystic Fibrosis Foundation Therapeutics.
- Article from:
- PR Newswire
- Article date:
- October 4, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Also Presents Phase I/II Results and Receives Fast Track Designation for INS37217 Respiratory for Cystic Fibrosis
Inspire Pharmaceuticals, Inc. today announced a collaboration with Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), a non-profit drug development affiliate of the Cystic Fibrosis Foundation, that will provide funding of a Phase II study for INS37217 Respiratory for the treatment of cystic fibrosis (CF). The Phase II study is being conducted based on results from a recently completed Phase I/II study. These results will be presented at the 16th Annual North American Cystic Fibrosis Conference, October 3-6 in New Orleans. In addition, Inspire ...